The Bipolar Disorders: Improving Diagnosis, Guidance and Education (BRIDGE)-II-Mix study aimed to estimate the frequency of mixed states in patients with a major depressive episode (MDE) according to different definitions. The present post-hoc analysis evaluated the association between obesity and the presence of mixed features and bipolarity.
| INTRODUCTION
One of the main challenges in the diagnostic assessment of mood disorders is the early detection of bipolarity and mixed features in patients with a major depressive episode (MDE), in order to distinguish unipolar depression from bipolar disorder (BD), with relevant clinical and treatment implications. 1, 2 In fact, several epidemiological and clinical studies reported that almost 40% of BD patients initially receive the incorrect diagnosis of major depressive disorder (MDD).
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In primary care settings, a careful screening for mixed features enables the identification of BD in 21%-26% of unipolar depressed patients. 6, 7 In the Bipolar Disorders: Improving Diagnosis, Guidance and Education (Bridge) study, in 5635 adults with an ongoing MDE, a total of 903 patients fulfilled DSM-IV-TR criteria for BD, whereas 2647 met the bipolarity specifier criteria. [8] [9] [10] Growing evidence suggests an increased prevalence of mood disorders, and in particular BD, among individuals who are overweight or OB compared to those with weight in the normal range. 11, 12 A relationship between depression, especially with atypical features, and obesity has been widely demonstrated. [13] [14] [15] Moreover, atypical symptoms in depressed patients have been associated with both obesity and BD. 16 Notably, obese (OB) patients have been shown to have a higher risk of developing MDD and BD. 17 On the other hand, the course of bipolar depression is frequently affected by the development of overweight and obesity, which could be related to the effects of psychotropic medications or comorbid diagnosis with eating disorders such as binge eating disorder (BED). 12, 18 A recent meta-analysis of nine cross-sectional epidemiological studies confirmed that obesity is associated with an increased prevalence of BD; however, the mechanisms and temporal sequence underlying this relationship are poorly understood. 19 Regarding gender differences, women showed higher rates of atypical features, as well as a higher body mass index (BMI) than males, especially abdominal obesity. 16 Furthermore, the rate of obesity in women with BD has been found to be higher than in men with BD. 20 The co-occurrence of BD and obesity seems to have a negative effect on the course and longterm prognosis of BD. 21 A greater number of lifetime depressive and manic episodes, more severe and difficult-to-treat index affective episode, higher rate of affective recurrence (predominantly depressive), and shorter time to relapse were more frequently reported in OB than in nonobese (NOB) BD patients. 22 A recent study sample of 571 consecutive patients with an MDE suggested that obesity could be considered as a predictor of bipolarity. 23 However, to our knowledge, the prevalence of mixed features (according to the definition of the DSM-5 and the research-based diagnostic criteria [RBDC] ) and bipolarity (according to the bipolarity specifier criteria and the DSM-IV-R for BD)
in OB and NOB patients with an MDE has not been systematically investigated.
The objective of the Bipolar Disorders: Improving Diagnosis, Guidance and Education (BRIDGE)-II-Mix 24-26 naturalistic study was to provide a reliable estimate of the frequency of mixed states in a large international sample of patients diagnosed with an MDE according to several sets of criteria.
The aim of the present post-hoc analysis was to compare the characteristics of patients diagnosed with an MDE who presented with a BMI ≥30 (MDE-OB) to those of patients with a BMI <30 (MDE-NOB).
We aimed to characterize the MDE-OB patients in order to clarify the correlation between mixed features, bipolarity, and obesity. We also discuss the possible clinical and treatment implications of this association.
| PATIENTS AND METHODS
The BRIDGE-II-Mix study was a multicenter, international, noninterventional, cross-sectional study. The recruitment procedure and the inclusion criteria have been described in a previous study. 24 From an initial pool of 2811 patients with an MDE, BMI was evaluated in 2744 patients. A total of 493 (18%) patients presented with a BMI ≥30. 
| Data collection

| Statistical analysis
The chi-square test was used for comparison between groups for cat- 
| RESULTS
| Differences in clinical variables between MDE-OB and MDE-NOB
According to the DSM-IV-TR criteria, a diagnosis of BD was detected 
| Differences in the frequency of (hypo)manic symptoms between MDE-OB and MDE-NOB
The MDE-OB patients showed 11 out of the 14 RBDC (hypo)manic symptoms with a significantly higher prevalence compared to the MDE-NOB patients (P<.001) ( Table 4 ). In multivariate logistic regression analysis, the (hypo)manic symptoms most strongly associated with obesity were psychomotor agitation, distractibility, increased energy, and risky behavior (Table 5 ).
| DISCUSSION
In our multinational sample of 2744 patients with MDE, obesity was found to be relatively common (18%), in line with the results of previous studies, supporting the strong association between depression and obesity. 23 T A B L E 2 Clinical features in 2744 patients with a major depressive episode (MDE) with (MDE-OB) and without (MDE-NOB) obesity (BMI ≥30) features. 14, 33 Symptoms such as leaden paralysis, increased appetite, overeating, oversleeping, and reduced physical activity might explain the weight gain in atypical depressive patients. 34 Atypical features have been associated with both BD and BED. 35 Thus, the specific association between BD and obesity might be partly explained by these overlapping atypical symptoms. Our results also showed a relationship between obesity and female gender in MDE patients, similarly to previous findings. 36 Interestingly, women present more frequently with depression with atypical features, 16 and this association could represent the link between obesity and female gender. The relationship between obesity and BD has been associated with a predominant depressive polarity of BD. 22, 37, 38 Similarly, in our sample obesity was associated with a history of more than three previous MDEs, supporting the relevant role of depression in developing overweight.
MDE-OB patients were more frequently married than MDE-NOB, which might have been, at least in part, related to the older age of this group of patients. Moreover, the positive relationship that we found between MDE-OB patients and older age, also reported in previous studies, 32, 39, 40 could be partially explained by the exposure to psychopharmacological treatment over a longer time period.
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Of note, in our sample the MDE-OB group was treated significantly more frequently with antipsychotic agents than the MDE-NOB group.
Antipsychotic agents are known to be associated with obesity, 44 even though other studies have reported that about 40% of drug-naïve BD T A B L E 3 Multiple logistic regression backward procedure of clinical features, bipolarity, and mixed-state diagnosis on the presence of obesity (BMI ≥30) in 2744 subjects with a major depressive episode (MDE) found that comorbidity with eating disorders and anxiety disorders was more frequently reported in MDE-OB patients than in MDE-NOB subjects. A recent post-hoc analysis of the BRIDGE-II-mix study showed that comorbidities with eating disorders and anxiety disorders were more frequently associated with a BD diagnosis. 50 In this sense, a possible association between obesity, eating disorders, and bipolar spectrum disorders could be hypothesized, in line with previous findings. 49 This comorbidity has been associated with an increased severity of eating behaviors, poorer prognosis for obesity, and treatment resistance in BD. 22, 49, 51 In our sample, a first-degree family history of BD, antidepressant-induced (hypo)manic switches, and psychotic features were more frequent in MDE-OB patients than in MDE-NOB patients. Moreover, regardless of the diagnostic criteria applied, the presence of mixed features was significantly more prevalent in the MDE-OB patients than in MDE-NOB subjects. After multiple logistic regression, DSM-5 mixed features were found to be the most significantly variable correlated with obesity. Taken together, these results appear to support the hypothesis of a relationship between obesity and the bipolar spectrum. It has been suggested that the presence of lifetime (hypo)manic symptoms and mood instability may lead to impulsive-addictive behaviors, such as uncontrolled eating. 23 In our sample, most of the RBDC (hypo)manic symptoms were more prevalent in the MDE-OB group compared to the MDE-NOB subjects. This association might represent a link between bipolar spectrum disorders and obesity.
The main strengths of the BRIDGE-Mix II study included the large sample size and the wide range of care settings, both hospital and community, from eight countries across three continents. The narrow exclusion criteria helped to make the findings more generalizable.
The major limitation was that the participating centers were not randomly selected, which may have led to a bias through the inclusion of psychiatrists with a particular interest in mixed states. Furthermore, among comorbid eating disorders, the BED subtype was not specified.
In addition, the lack of complete biometric data (waist circumference) might have led to an under-detection of abdominal obesity, especially in women.
| CONCLUSION
From the results of our study, MDE-OB patients seem to present with higher rates of bipolarity and mixed features than MDE-NOB individuals, indicating that obesity could be investigated as a possible biomarker for bipolar spectrum disorders. The identification of individuals with MDE and obesity as a subset of patients at higher risk of presenting with mixed and hypomanic symptoms should lead to a more comprehensive clinical evaluation, in order to achieve a prompt detection of bipolar spectrum disorders. This would have important clinical and treatment implications, such as tailored behavioral psychological interventions. 52 Further longitudinal data on different populations will be necessary to better define both the burden and the role of the association between obesity and mood disorders on correct diagnosis, treatment response, and clinical outcome.
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